Primary treatment approaches for women with urgency urinary incontinence (UUI) include medications and behavioral therapy. Patients with UUI refractory to primary treatments may be offered third-line treatment options such as sacral neuromodulation (SNM) or onabotulinumtoxinA.
Characteristics associated with treatment response and satisfaction in women undergoing onabotulinumtoxinA and sacral neuromodulation for refractory urgency urinary incontinence
Richter, H. E., Amundsen, C. L., Erickson, S. W., Jelovsek, J. E., Komesu, Y., Chermansky, C., Harvie, H. S., Albo, M., Myers, D., Gregory, W. T., Wallace, D., & NICHD Pelvic Floor Disorders Netwo (2017). Characteristics associated with treatment response and satisfaction in women undergoing onabotulinumtoxinA and sacral neuromodulation for refractory urgency urinary incontinence. Obstetrical & Gynecological Survey, 72(12), 709-711. https://doi.org/10.1097/01.ogx.0000527551.60666.74
Abstract
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.